Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11

NCT00000259 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Interventions

DRUG: 15 % Nitrous oxide
DRUG: 0.3 % Sevoflurane
DRUG: 30% Nitrous oxide
DRUG: 0.6% Sevoflurane
OTHER: Placebo

Sponsor

University of Chicago

Collaborators

[object Object]